SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-009247
Filing Date
2022-05-23
Accepted
2022-05-23 08:00:22
Documents
12
Period of Report
2022-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20220520x8k.htm   iXBRL 8-K 37471
  Complete submission text file 0001558370-22-009247.txt   158950

Data Files

Seq Description Document Type Size
2 EX-101.SCH agrx-20220520.xsd EX-101.SCH 3183
3 EX-101.LAB agrx-20220520_lab.xml EX-101.LAB 15934
4 EX-101.PRE agrx-20220520_pre.xml EX-101.PRE 10138
6 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20220520x8k_htm.xml XML 4858
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 22949612
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences